Reinnervate Expands its Distribution Network for Alvetex® in Asia and Australia
News Aug 25, 2011
Reinnervate, has announced partnerships with six new regional distributors for the non-exclusive distribution and sale of alvetex®, its breakthrough 3D cell culture technology, in the Asia-Pacific region.
Under the terms of the agreements alvetex® will be distributed and sold under the reinnervate brand by leading regional distributors of life sciences research products: Scrum Inc. and Takara Bio (Japan) , Shanghai Pufei Bio-Technology Co., Ltd (China), Unimed Healthcare Inc (Taiwan), KDR Biotech Co. Ltd (Korea), and BioScientific Pty. Ltd (Australia).
Richard Rowling, Commercial Director of reinnervate, commented: “The expansion of our distributor network to cover the rapidly growing Asian and Australian markets is a great step forward for us. Our mission is to enable researchers around the world to use 3D cell culture routinely and through these partnership agreements researchers within the Asia-Pacific region will, for the first time, have access to our game-changing alvetex® technology. In alvetex, we believe we have a unique product that is capable of revolutionizing 3D cell culture and unlocking the enormous potential of this important area of scientific research. We have been hugely impressed by the level of interest in our technology since we launched alvetex® in November 2010 and there appears to be growing demand for our product across the Asia-Pacific region as researchers increasingly move towards better in-vitro models that utilize 3D cell culture.”
Tight junctions are multi-protein complexes that serve as barriers in epithelial tissues such as the skin or lining of the gut. Loss of a specific tight junction barrier protein, claudin 18, occurs in the majority of gastric cancer patients and is correlated with poor prognosis in patients with advanced gastric cancer.READ MORE